Humanitas Cancer Center, Istituto Clinico Humanitas IRCCS

Rozzano 20089

0 studies enrolling now · 1 studies all time

What they study most

Combined Hepatocellular and Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma

Studies at this site

• Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma — Completed